Page last updated: 2024-08-23

buserelin and Cardiovascular Diseases

buserelin has been researched along with Cardiovascular Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aro, J; Hansson, E; Juusela, H; Permi, J; Ruutu, M1
Moffat, LE1

Trials

2 trial(s) available for buserelin and Cardiovascular Diseases

ArticleYear
Polyestradiol phosphate (160 mg/month) or LHRH analog (buserelin depot) in the treatment of locally advanced or metastasized prostatic cancer. The Finnprostate Group.
    Annales chirurgiae et gynaecologiae. Supplementum, 1993, Volume: 206

    Topics: Adenocarcinoma; Aged; Buserelin; Cardiovascular Diseases; Estradiol; Estradiol Congeners; Finland; Humans; Male; Prospective Studies; Prostatic Neoplasms

1993
Comparison of Zoladex, diethylstilbestrol and cyproterone acetate treatment in advanced prostate cancer.
    European urology, 1990, Volume: 18 Suppl 3

    Topics: Androgen Antagonists; Breast; Buserelin; Cardiovascular Diseases; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Goserelin; Humans; Male; Prospective Studies; Prostatic Neoplasms

1990